ATHEROSCLEROSIS
Clinical trials for ATHEROSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROSIS trials appear
Sign up with your email to follow new studies for ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm 'Fire' in hardened arteries
Disease control Not yet recruitingThis study is testing whether a new drug called selnoflast can reduce inflammation in the arteries of people with atherosclerosis (hardened arteries) who are at high risk for heart attacks or strokes. About 162 participants who are already on standard heart medications will recei…
Matched conditions: ATHEROSCLEROSIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
AI heart scan could spot hidden heart disease risk
Diagnosis Not yet recruitingThis study is testing a new AI software tool called CaRi-Heart® that analyzes standard heart CT scans to measure hidden inflammation in the arteries. The goal is to see if this extra information helps doctors make better decisions about treatment and early management for patients…
Matched conditions: ATHEROSCLEROSIS
Phase: NA • Sponsor: Corazon Medical PC • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC
-
Silent threat: ultrasound hunt for hidden artery disease in High-Risk patients
Knowledge-focused Not yet recruitingThis study aims to find out how common early artery disease is in people who have both type 2 diabetes and chronic kidney disease. Researchers will use a simple, safe neck ultrasound to check for early signs of artery hardening in 96 participants. The goal is to gather informatio…
Matched conditions: ATHEROSCLEROSIS
Sponsor: Abdallah Ali Mohammed • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:21 UTC